Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients

Transplantation

Volumn 67, Issue 7, 1999, Pages 1068-1070

  Kogan, Debora L ^a   Burroughs, Margaret ^a   Emre, Sukru ^a   Fishbein, Thomas ^a   Moscona, Anne ^a   Ramson, Carlena ^a   Shneider, Benjamin L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; VIREMIA; VIRUS LOAD;

EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; LYMPHOPROLIFERATIVE DISORDERS; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; VIRAL LOAD; VIREMIA;

EID: 0033561312     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904150-00023     Document Type: Article

References (10)

1. Matalack JJ, Gartner JC, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern. J Pediatr 1991; 118: 667.
2. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996; 62: 370.
3. Sokal EM, Atunes H, Beguin C, et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related post-transplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 1997; 64: 1438.
4. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein-Barr virus serology and Epstein-Barr virus associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993; 56: 1394.
5. Snydman DR, Werner BG, Dougherty NN, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. Ann Intern Med 1993; 119: 984.
6. Riddler SA, Breinig MC, McKnight JLC. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994; 84: 972.
7. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein- Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995; 60: 547.
8. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Micribiol 1997; 35: 1612.
9. Green M, Reyes J, Jabbour N, et al. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc 1996; 28: 2759.
10. Morgan G, Superina RA. Lymphoproliferative disease after pediatric liver transplantation. J Ped Surg 1994; 29: 1192.